||1. Till J. E. & McCulloch, E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 14:213-22 (1969).|
2. Fang, Z. F., H. Gai, et al. (2006). Rabbit embryonic stem cell lines derived from fertilized, parthenogenetic or somatic cell nuclear transfer embryos, Elsevier. 312: 3669-3682.
3. Suemori, H., T. Tada, et al. (2001). Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI, Wiley Online Library. 222: 273-279.
4. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A.,
Swiergiel, J. J.,Marshall, V. S. & Jones, J. M. Embryonic stem cell
lines derived from human blastocysts.Science 282:1145-7(1998).
5. Oh, S.H., et al., Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest, 2004. 84(5): p. 607-17.
6. Pittenger, M.F., et al., Multilineage potential of adult human mesenchymal stem cells. science, 1999. 284(5411): p. 143-7.
7. Gatti, R., Meuwissen, H., Allen, H., Hong, R. & Good, R. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. The Lancet 292:1366-1369 (1968).
8. Bach, F., Albertini, R., Joo, P., Anderson,J. & Bortin, M. Bone-marrow transplantation in a patient with the wiskott-aldrich syndrome. The Lancet 292:1364-1366 (1968).
9. Barinaga, M. Fetal neuron grafts pave the way for stem cell therapies. Science 287:1421-1422 (2000).
10. Lovell-Badge, R. The future for stem cell research. Nature 414:88-91 (2001).
11. Wobus, A.M. and K.R. Boheler, Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev, 2005. 85(2): p. 635-78.
12. Takahashi, K. and S. Yamanaka (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Elsevier. 126: 663-676
13. Charles A. Goldthwaite, J., Ph.D. , The promIse of Induced pluripotent stem cells(ipscs). Stem cell information NIH, 2010.
14. Semb, H., Human embryonic stem cells: origin, properties and applications. APMIS, 2005. 113(11-12): p. 743-50.
15. Chambers, S.M., et al., Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol, 2009. 27(3): p. 275-80.
16. Yokoo, N., S. Baba, et al. (2009). The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells, Elsevier. 387: 482-488.
17. Lian, Q., Y. Chow, et al. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases. 104: 39.
18. CONGER, K., Dramatic transformation: Researchers directly turn mouse skin cells into neurons, skipping IPS stage. Stanford school of medicine, 2010
19. Yu J. et al., 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science. 318(5858):1917-20.
20. Nakagawa M. et al., 2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 26(1):101-6.
21. Kim JB. et al., 2009. Oct4-induced pluripotency in adult neural stem cells. Cell. 136(3):411-9. 9. Sommer CA. et al., 2009.
22. Sommer, C.A., Stadtfeld, et al. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells. 27(3):543-9.
23. Evans, T., E.T. Rosenthal, J. Youngblom, D. Distel, and T. Hunt.
1983. Cyclin: A protein specified by maternal mRNA in sea
urchin eggs that is destroyed at each cleavage division. Ceil
24. Swenson, K., K.M. Farrell, and J.V. Ruderman. 1986. The clam
embryo protein cyclin A induces entry into M-phase and the
resumption of meiosis in Xenopus oocytes. Cell 47: 861-870.
25. Baldin, V., J. Lukas, et al. (1993). Cyclin D1 is a nuclear protein required for cell cycle progression in G1, Cold Spring Harbor Lab. 7: 812-821.
26. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate
with multiple protein kinases and the DNA replication
and repair factor PCNA. Cell 71: 505-514.
27. Wang C, Li Z, Fu M, Bouras T, Pestell RG 2004. Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential. Cancer Treat Res 119:217–237.
28. Motokura T, Arnold A 1993. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5_ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer 7:89–95.
29. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB 1993. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196:1010–1016.
30. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J 1994. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353–361.
31. Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF 1995. Signaling by ABL oncogenes through cyclin D1. Proc Natl Acad Sci USA 92:9540–9544.
32. Callanan M, Leroux D, Magaud JP, Rimokh R 1996. Implication of cyclin D1 in malignant lymphoma. Crit Rev Oncog 7:191–203.
33. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger HG 1997. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 57:1634–1637.
34. Barnes DM, Gillett CE 1998. Cyclin D1 in breast cancer. Breast Cancer Res Treat 52:1–15.
35. Amanatullah DF, Zafonte BT, Albanese C, Fu M, Messiers C, Hassell J, Pestell RG 2001. Ras regulation of cyclin D1 promoter. Methods Enzymol 333:116–127.
36. Diehl JA 2002. Cycling to cancer with cyclin D1. Cancer Biol Ther 1:226–231.
37. Stacey DW 2003. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 15:158–163.
38. ChungDC 2004. Cyclin D1 in human neuroendocrine: tumorigenesis. AnnNY Acad Sci 1014:209–217.
39. Motokura, T., T. Bloom, Y.G. Kim, H. Jueppner, J. Ruderman,
H. Kronenberg, and A. Arnold. 1991. A novel cyclin encoded by a bcll-linked candidate oncogene. Nature 350:512-515.
40. Rosenberg, C., H. Kim, T. Shows, H. Kronenberg, and A. Arnold.
1991. Rearrangement and overexpression of DllS287E, a candidate oncogene on chromosome 1 lq13 in benign parathyroid
tumors. Oncogene 6: 449-453.
41. Lammie, G., V. Fantl, R. Smith, E. Schuuring, S. Brookes, R. Michalides, C. Dickson, A. Arnold, and G. Peters. 1991. D11S287, a putative oncogene on chromosome 1 lq13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6: 439-444.
42. Jiang, W., S. Kahan, N. Tomita, Y. Zhang, S. Lu, and B. Weinstein.
1992. Amplification and expression of the human cydin D gene in esophageal cancer. Cancer Res. 52: 2980-2983.
43. Fu, M., C. Wang, et al. (2004). Minireview: Cyclin D1: normal and abnormal functions, Endocrine Soc. 145: 5439-5447.
44. Jirmanova, L., M. Afanassieff, et al. (2002). Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. 21: 5515-5528.
45. Artegiani, B., D. Lindemann, et al. Overexpression of cdk4 and cyclinD1 triggers greater expansion of neural stem cells in the adult mouse brain, Rockefeller Univ Press. 208: 937-948.
46. Edel, M. J., C. Menchon, et al. Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1, Cold Spring Harbor Lab. 24: 561-573.
47. Albanese, C., M. D’Amico, et al. (1999). Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis, ASBMB. 274: 34186-34195.
48. Holnthoner, W., M. Pillinger, et al. (2002). Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells, ASBMB. 277: 45847-45853.
49. Nelsen CJ, Rickheim DG, Tucker MM, McKenzie TJ, Hansen LK, Pestell RG, Albrecht JH 2003. Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression. J Biol Chem 278:25853–25858.
50. Hu YL, Albanese C, Pestell RG, Jaffe RB 2003. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J Natl Cancer Inst 95:733–740.
51. Fu, M., M. Rao, et al. (2003). Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth, Am Soc Microbiol. 23: 8563-8575.
52. Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB 2002. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res 62:3997–4006.
53. Wang, C., N. Pattabiraman, et al. (2003). Cyclin D1 repression of peroxisome proliferator-activated receptor γ expression and transactivation, Am Soc Microbiol. 23: 6159-6173.
54. Iyengar, P., T. P. Combs, et al. (2003). Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization, Nature Publishing Group. 22: 6408-6423.
55. Song DH, Rana B, Wolfe JR, Crimmins G, Choi C, Albanese C, Wang TC, Pestell RG, WolfeMM 2003. Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. Am J Physiol Gastrointest Liver Physiol 285:G217–G222.
56. Pradeep, A., C. Sharma, et al. (2004). Gastrin-mediated activation of cyclin D1 transcription involves β-catenin and CREB pathways in gastric cancer cells, Nature Publishing Group. 23: 3689-3699.
57. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7:812–821.
58. Sherr CJ 2000. The Pezcoller Lecture: cancer cell cycles revisited. Cancer Res 60:3689–3695.
59. Dey A, Li W 2000. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFN-γ in macrophages. Biochim Biophys Acta 1497:135–147.
60. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A 1999. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501–534.
61. Zhang JM, Wei Q, Zhao X, Paterson BM 1999. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. EMBO J 18:926–933.
62. Horstmann S, Ferrari S, Klempnauer KH 2000. Regulation of B-Myb activity by cyclin D1. Oncogene 19:298–306.
63. Inoue, K. and C. J. Sherr (1998). Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism, Am Soc Microbiol. 18: 1590-1600.
64. Knudsen KE, Cavenee WK, Arden KC 1999. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res 59:2297–2301.
65. Reutens, A. T., M. Fu, et al. (2001). Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner, Endocrine Soc. 15: 797-811.
66. Petre CE, Wetherill YB, Danielsen M, Knudsen KE 2002. Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity. J Biol Chem 277:2207–2215.
67. Petre-Draviam CE, Cook SL, Burd CJ, Marshall TW, Wetherill YB, Knudsen KE 2003. Specificity of cyclin D1 for androgen receptor regulation. Cancer Res 63:4903–4913.
68. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ 1997. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405–415.
69. Neuman, E., M. H. Ladha, et al. (1997). Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4, Am Soc Microbiol. 17: 5338-5347.
70. Lamb J, Ladha MH, McMahon C, Sutherland RL, EwenME2000. Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol Cell Biol 20:8667–8675.
71. McMahon C, Suthiphongchai T, DiRenzo J, Ewen ME 1999. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc Natl Acad Sci USA 96:5382–5387.
72. Lamb J, Ewen ME 2003. Cyclin D1 and molecular chaperones: implications for tumorigenesis. Cell Cycle 2:525–527.
73. Kim, J. K. and J. A. Diehl (2009). Nuclear cyclin D1: an oncogenic driver in human cancer, Wiley Online Library. 220: 292-296.
74. Becker, K. A., P. N. Ghule, et al. (2006). Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase, Wiley Online Library. 209: 883-893.
75. Savatier, P., S. Huang, et al. (1994). Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts, Basingstoke, Hampshire, UK: Scientific & Medical Division, Macmillan Press, c1987-. 9: 809-818.
76. Boheler, K. R. (2009). Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle, Wiley Online Library. 221: 10-17.
77. Greer Card, D. A., P. B. Hebbar, et al. (2008). Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells, Am Soc Microbiol. 28: 6426-6438.